Analyzing the factors associated with efficacy among teriparatide treatment in postmenopausal women with osteoporosis

Abstract Background Teriparatide (TPTD) is a widely used anabolic agent for the treatment of osteoporosis. Several factors have been identified to be related to bone mineral density (BMD) increase in anti-osteoporosis treatment with other agents; however, there has been no systematic analysis to sum...

Full description

Bibliographic Details
Main Authors: Meng Kong, Changtong Gao, Xiaona Luan, Cuiying Fan, Meng Hao, Canghai Jin, Jiangning Zhao, Hongyan Li, Jindong Zhao, Jian Luan, Yong Lin, Qiang Li
Format: Article
Language:English
Published: BMC 2024-02-01
Series:BMC Musculoskeletal Disorders
Subjects:
Online Access:https://doi.org/10.1186/s12891-024-07227-1